File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Conference Paper: A Phase 2 Study of the LSD1 Inhibitor Img-7289 (bomedemstat) for the Treatment of Advanced Myelofibrosis

TitleA Phase 2 Study of the LSD1 Inhibitor Img-7289 (bomedemstat) for the Treatment of Advanced Myelofibrosis
Authors
Issue Date2021
PublisherAmerican Society of Hematology. The Journal's web site is located at http://bloodjournal.hematologylibrary.org/
Citation
2021 American Society of Hematology (ASH) 63rd Meeting & Exposition, Atlanta, Georgia, USA, 10-14 December 2021. In Blood, v. 138 n. Suppl. 1, abstract no. 139 How to Cite?
DescriptionOral Abstract - Session 634. Myeloproliferative Syndromes: Clinical and Epidemiological: Non-JAK inhibitor Therapies for Myelofibrosis
Persistent Identifierhttp://hdl.handle.net/10722/309389
ISSN
2023 Impact Factor: 21.0
2023 SCImago Journal Rankings: 5.272
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorSingh, GHH-
dc.contributor.authorYacoub, A-
dc.contributor.authorPettit, KM-
dc.contributor.authorBradley, T-
dc.contributor.authorGerds, AT-
dc.contributor.authorTatarczuch, M-
dc.contributor.authorShortt, J-
dc.contributor.authorCurtin, NJ-
dc.contributor.authorRossetti, JM-
dc.contributor.authorBurbury, K-
dc.contributor.authorMead, AJ-
dc.contributor.authorGöthert, JR-
dc.contributor.authorKoschmieder, S-
dc.contributor.authorJones, A-
dc.contributor.authorPeppe, J-
dc.contributor.authorNatsoulis, G-
dc.contributor.authorHong, WJ-
dc.contributor.authorStevenson, WS-
dc.contributor.authorEwing, J-
dc.contributor.authorHarrison, CN-
dc.contributor.authorVannucchi, A-
dc.contributor.authorWatts, J-
dc.contributor.authorRoss, DM-
dc.contributor.authorTalpaz, M-
dc.contributor.authorRienhoff, HY-
dc.date.accessioned2021-12-29T02:14:25Z-
dc.date.available2021-12-29T02:14:25Z-
dc.date.issued2021-
dc.identifier.citation2021 American Society of Hematology (ASH) 63rd Meeting & Exposition, Atlanta, Georgia, USA, 10-14 December 2021. In Blood, v. 138 n. Suppl. 1, abstract no. 139-
dc.identifier.issn0006-4971-
dc.identifier.urihttp://hdl.handle.net/10722/309389-
dc.descriptionOral Abstract - Session 634. Myeloproliferative Syndromes: Clinical and Epidemiological: Non-JAK inhibitor Therapies for Myelofibrosis-
dc.languageeng-
dc.publisherAmerican Society of Hematology. The Journal's web site is located at http://bloodjournal.hematologylibrary.org/-
dc.relation.ispartofBlood-
dc.relation.ispartof2021 American Society of Hematology (ASH) 63rd Meeting & Exposition-
dc.titleA Phase 2 Study of the LSD1 Inhibitor Img-7289 (bomedemstat) for the Treatment of Advanced Myelofibrosis-
dc.typeConference_Paper-
dc.identifier.emailSingh, GHH: gillhsh@hku.hk-
dc.identifier.authoritySingh, GHH=rp01914-
dc.description.naturelink_to_OA_fulltext-
dc.identifier.doi10.1182/blood-2021-148682-
dc.identifier.hkuros331293-
dc.identifier.volume138-
dc.identifier.issueSuppl. 1-
dc.identifier.spage139-
dc.identifier.epage139-
dc.identifier.isiWOS:000736398800137-
dc.publisher.placeUnited States-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats